Center for Pharma Crystallization
J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
Are you facing challenges getting reliable single crystal structures of APIs or intermediate compounds?
You can get professional help from our leading crystallization expert with …
CfPC at J-STAR Research
Center for Pharma Crystallization, J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
See how the Center for Pharma Crystallization (CfPC) at J-STAR Research is effectively supporting new drug development programs: https://www.jstar-research.com/contract-rd-services/crystallization-rd/…
Solid Form Studies
Center for Pharma Crystallization, J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
Cure the pains caused by polymorphs, working with The Center for Pharma Crystallization (CfPC) at J-STAR Research.
Discover more about our approach
A…
Drug discovery is an exceedingly complex process. Discovering a new chemical entity is in itself a huge accomplishment, which is often possible only after almost two decades of hard experimental work as well as advanced simulation efforts. Therefore, the next …
Don Kientzler
Center for Pharma Crystallization, J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
Abstract
Controlled crystallization of an API in submicron size was enabled based on an accurate solubility profile and a growth inhibition property via semi-continuous …
Jian Wang
Center for Pharma Crystallization, J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
Abstract
Diverse crystallization challenges encountered by CfPC (Center for Pharma Crystallization) and our clients will be analyzed systematically to provide insights into main bottleneck …
Yuriy A. Abramov
yuriy.abramov@xtalpi.com
XtalPi Inc, Cambridge MA, USA.
Abstract
Given challenges facing the pharmaceutical industry, an accelerated Drug Development greatly benefits from guidance provided by computational methods.1 This presentation will focus on computational support of the following important tasks …
Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles of small molecule based medicines. In an effort to fully utilize existing tools and develop better new method-logies for solving …
Dr. William Glauser
XtalPi, Inc., USA
Abstract
Problems associated with polymorphic instability and increasingly insoluble drug candidates represent white space to innovate novel forms and processing methods with better properties in the drug product. But the journey from identifying new …
Dr. Shanming Kuang
Center for Pharma Crystallization, J-STAR Research Inc
6 Cedar Drive, Cranbury, New Jersey 08512
shanming.kuang@jstar-research.com
Abstract
Rational selection of solvents plays a critical role in solid form screening and production. On the one hand, a variety of …
